U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Mond

Gainers Redhill Biopharma (NASDAQ:RDHL) shares increased by 96.7% to $1.3 during Monday's pre-m

Shares of Webuy Global Ltd (NASDAQ:WBUY) rose sharply in pre-market trading. Webuy reported recor

Gainers Aardvark Therapeutics (NASDAQ:AARD) shares increased by 8.5% to $6.28 during Friday's a

Gainers Nuwellis (NASDAQ:NUWE) stock increased by 27.2% to $1.22 during Wednesday's pre-market

Gainers Picard Medical (AMEX:PMI) shares moved upwards by 82.7% to $9.38 during Tuesday's regul

Gainers Picard Medical (AMEX:PMI) shares moved upwards by 34.6% to $4.32 during Monday's pre-ma

Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares increased by 108.1% to $0.9 during Friday's

Jupiter Neurosciences, Inc. (NASDAQ:JUNS) ("Jupiter" or the "Company"), a clinical-s

Jupiter Neurosciences announced it has entered into a securities purchase agreement for the purchase

New York, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or

US stocks rise, Dow gains over 350 points as markets open Friday; Materials sector up 2%, utilitie

Shares of Jupiter Neurosciences Inc. (NASDAQ:JUNS) are surging Friday morning as related biotechnolo

Shares of Jupiter Neurosciences are surging Friday morning after partner PharmAla Biotech announced

Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares moved upwards by 74.6% to $0.75 during Friday&#3

Two developments have since materially changed the context for that structure. First, on July 20, 20

Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 43.0% to $1.43 during Wednesday&#

Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-

Jupiter's common stock is expected to begin trading on a post-split adjusted basis on August 7, 2026

Gainers Tenet Healthcare (NYSE:THC) stock increased by 17.3% to $233.54 during Friday's regular

Gainers NovoCure (NASDAQ:NVCR) shares moved upwards by 27.7% to $19.88 during Thursday's regula

Gainers InMed Pharmaceuticals (NASDAQ:INM) stock moved upwards by 66.8% to $2.57 during Wednesday&#

Gainers Jupiter Neurosciences (NASDAQ:JUNS) stock rose 36.4% to $0.23 during Tuesday's pre-mark

Agreement expands Jupiter from a single-program company into a dual clinical-stage CNS developer. Ma

Transaction expands Jupiter into a dual clinical-stage CNS company by adding a differentiated FDA-de

Former White House Council of Economic Advisors Brings Extensive Government, Academic, and Private S

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 284.8% to $11.39 during Monday

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 159.6% to $7.68 during Monday&

Universe Pharmaceuticals Inc (NASDAQ: UPC) surged 228.4% to $9.72 in pre-market trading after announ

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 168.2% to $7.94 during Friday&

T TO COMPLETION, DATED JUNE 26, 2026   Jupiter Neurosciences, Inc. 16,000,000 Shares of Common Stock

Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage biopharmaceutical company developing in

Investigational Oral Candidate JOTROL ™ Addresses a Parkinson's Disease Market with No Current Disea

NEW YORK CITY, NY / ACCESS Newswire / May 26, 2026 / Jupiter Neurosciences, Inc. (NASDAQ:JUNS) ("Jup

Cash Runway Extended to Finance the Parkinson's Program; Debt Paydown Improves Shareholder Equity Po

https://www.sec.gov/Archives/edgar/data/1679628/000149315226024740/form424b5.htm

Shares of elf Beauty Inc (NYSE: ELF) rose sharply in pre-market trading after beating analyst expect

Jupiter, FL, May 20, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter"

Jupiter Neurosciences, Inc. (NASDAQ:JUNS) shares are trading higher Wednesday after the company anno

Jupiter Neurosciences shares are rising Wednesday after it announced the acquisition of US licensing

PharmAla Biotech Holdings Inc. (CSE:MDMA, OTCQB:MDXXF) ("PharmAla" or the "Company")

PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002 to Jupiter Neuroscienc

 The shares will be subject to a 120-day Lock-up period. The term sheet also provides that additiona

Transaction Positions JUNS at the Forefront of Next-Generation MDMA-Based Therapeutics Following Pre

Jupiter Neurosciences (NASDAQ:JUNS) reported quarterly losses of $(0.06) per share which missed the